Pure Bioscience's total assets for Q1 2026 were $1.19M, an increase of 12.10% from the previous quarter. PURE total liabilities were $6.73M for the fiscal quarter, a 9.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.